We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Novel Stress Biomarker Measurement Method Uses UV Range

By LabMedica International staff writers
Posted on 04 Jun 2019
Print article
Image: An instrument used for manufacturing test strips to measure stress biomarkers (Photo courtesy of Andrew Higley, University of Cincinnati).
Image: An instrument used for manufacturing test strips to measure stress biomarkers (Photo courtesy of Andrew Higley, University of Cincinnati).
A recent paper described a novel label-free method for quantitative detection of human performance “stress” biomarkers in different body fluids that is based on optical absorbance of biomarkers in the ultraviolet (UV) range of the spectrum.

The concentrations of stress biomarkers (hormones and neurotransmitters) in bodily fluids (blood, sweat, urine, and saliva) predict the physical and mental state of the individual. In the current study, investigators at the University of Cincinnati (OH, USA) focused on the stress biomarkers cortisol, serotonin, dopamine, norepinephrine, and neuropeptide Y.

The investigators characterized the UV properties of individual and multiple biomarkers in various biological fluids using a microfluidic/optoelectronic platform for biomarker detection in the 190-400 nm range.

For this study the prime focus was cortisol evaluation. The current limit of detection of cortisol in sweat is approximately 200 nanograms per milliliter, which is in the normal range. UV measurement revealed that plasma samples containing both serotonin and cortisol resulted in readily detectable absorption peaks at 203 (serotonin) and 247 (cortisol) nanometers, confirming the feasibility of simultaneous detection of multiple biomarkers in biological fluid samples. UV spectroscopy performed on various stress biomarkers showed a similar increasing absorption trend with concentration.

The investigators reported that the detection mechanism was label free, applicable to a variety of biomarker types, and able to detect multiple biomarkers simultaneously in various biofluids. A microfluidic flow cell was fabricated on a polymer substrate to enable point-of-care UV measurement of target biomarkers. The overall sensor combined sample dispensing and fluid transport to the detection location with optical absorption measurements with a UV light emitting diode (LED) and photodiode.

"I wanted something that is simple and easy to interpret," said senior author Dr. Andrew Steckl, professor of electrical engineering at the University of Cincinnati. "This may not give you all the information, but it tells you whether you need a professional who can take over. These stress biomarkers are found in all of these fluids, albeit in different quantities. It measures not just one biomarker but multiple biomarkers. And it can be applied to different bodily fluids. That is what is unique."

"You are not going to replace a full-panel laboratory blood test. That is not the intent," said Dr. Steckl. "But if you are able to do the test at home because you are not feeling well and want to know where you stand, this will tell whether your condition has changed a little or a lot."

The UV test for stress biomarkers was described in the May 24, 2019, issue of the journal American Chemical Society Sensors.

Related Links:
University of Cincinnati

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.